April 18, 2025

Intranasal Diazepam Gains Expanded Approval for Pediatric Patients

“Approval of an immediate-use intranasal diazepam treatment that can be given at any time—even while a child is actively seizing—in this young age group is an important advance for the epilepsy community.”

Conexiant

April 16, 2025

CONSORT 2025: Setting New Standards for Clinical Trial Reporting

"Readers should not have to infer what was probably done; they should be told explicitly." This principle drives the comprehensive CONSORT 2025 update, with its 7 new checklist items aimed at improving clinical trial transparency.

Conexiant

April 15, 2025

AASM: Sleepiness a "Critical" Patient-Reported Outcome

"Excessive sleepiness — the inability to stay awake and alert during the major waking episodes of the day — is reported by one-third of U.S. adults," warns the AASM in a new position statement with implications for clinical practice.

Conexiant

April 14, 2025

Best Hour to Start the Day? Study Defends DST

DST aligns human activity with natural light cycles at middle latitudes and addresses fundamental chronobiological needs.

Conexiant

April 14, 2025

1 in 5 Patients Face Stroke Within Decade After TIA

Meta-analysis of 171,000+ patients shows persistent long-term stroke risk following TIA, with half of recurrent events occurring after the first year.

Conexiant

April 10, 2025

Insomnia, Short Sleep Raise Teen BP

New research links insomnia and short sleep duration to significantly increased risk of high blood pressure in adolescents.

Conexiant

April 10, 2025

Diagnosed ADHD Associated with Reduced Lifespan

Adults diagnosed with ADHD in the UK had shorter life expectancy than matched peers

Conexiant

April 09, 2025

Daytime Eating Protects Night Shift Hearts

Restricting meals to daytime hours may reduce cardiovascular changes during simulated night shifts.

Conexiant

April 08, 2025

Distressing Dreams Tied to Early Death, Study

Adults with frequent nightmares face nearly triple the risk of premature mortality.

Conexiant